22
Views
160
CrossRef citations to date
0
Altmetric
Cell Growth and Development

The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells

, , , , , , , , , , , , & show all
Pages 5902-5912 | Received 11 Mar 1999, Accepted 03 Jun 1999, Published online: 27 Mar 2023

REFERENCES

  • Aznavoorian, S., A. N. Murphy, W. G. Stetler-Stevenson, and J. Liotta 1993. Molecular aspects of tumor cell invasion and metastasis. Cancer 71:1368–1383.
  • Curran, T., G. Peters, C. Van Beveren, N. M. Teich, and J. Verma 1982. FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA. J. Virol. 44:674–682.
  • Droz, D., N. Patey, F. Paraf, Y. Chretien, and J. Gogusev 1994. Composition of extracellular matrix and distribution of cell adhesion molecules in renal cell tumors. Lab. Investig. 71:710–718.
  • Friedhelm, B., S. Riethmacher, S. Isenmann, A. Aaguzzi, and J. Birchmeier 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into limb bud. Nature 376:768–771.
  • Gnarra, J. R., D. Duan, Y. Weng, J. S. Humphrey, D. Y. Chen, S. Lee, A. Pause, C. F. Dudley, F. Latif, I. Kuzmin, L. Schmidt, F. M. Duh, T. Stackhouse, F. Chen, T. Kishida, M. H. Wei, M. I. Lerman, B. Zbar, R. D. Klausner, and J. Linehan 1996. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim. Biophys. Acta 1242:201–210.
  • Gnarra, J. R., K. Tory, Y. Weng, L. Schmidt, M. H. Wei, H. Li, F. Latif, S. Liu, F. Chen, F.-M. Duh, I. Lubensky, D. R. Duan, C. Florence, R. Pozzatti, M. M. Walther, N. H. Bander, H. B. Grossman, H. Brauch, S. Pomer, J. D. Brooks, W. B. Isaacs, M. I. Lerman, B. Zbar, and J. Linehan 1994. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet. 7:85–90.
  • Gnarra, J. R., S. Zhou, M. J. Merrill, J. R. Wagner, A. Krumm, E. Papavassiliou, E. H. Oldfield, R. D. Klausner, and J. Linehan 1996. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93:10589–10594.
  • Heussen, C., and J. Dowdle 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102:196–202.
  • Igawa, T., S. Kanda, H. Kanetake, Y. Saitoh, A. Ichihara, Y. Tomita, and J. Nakamura 1991. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 174:831–838.
  • Iliopoulos, O., A. Kibel, S. Gray, and J. Kaelin 1995. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1:822–826.
  • Iliopoulos, O., A. P. Levy, C. Jiang, W. G. Kaelin Jr., and J. Goldberg 1996. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93:10595–10599.
  • Iyer, A., T. E. Kmiecik, M. Park, I. Daar, D. Blair, K. J. Dunn, P. Sutrave, J. N. Ihle, M. Bodescot, and J. Vande Woude 1990. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ. 1:87–95.
  • Jeffers, M., M. Fiscella, C. P. Webb, M. Anver, S. Koochekpour, and J. Vande Woude 1998. The mutationally activated Met receptor mediates motility and metastasis. Proc. Natl. Acad. Sci. USA 95:14417–14422.
  • Jeffers, M., S. Rong, M. Oskarsson, M. Anver, and J. Vande Woude 1996. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastatic phenotype in C127 cells. Oncogene 13:853–861.
  • Jeffers, M., S. Rong, and J. Vande Woude 1996. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol. 16:1115–1125.
  • Jeffers, M., S. Rong, and J. Vande Woude 1996. Hepatocyte growth factor/scatter factor-Met signalling in tumorigenicity and invasion/metastasis. J. Mol. Med. 74:505–513.
  • Kawaida, K., K. Matsumoto, H. Shimazu, and J. Nakamura 1994. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc. Natl. Acad. Sci. USA 91:4357–4361.
  • Khokha, R., P. Waterhouse, S. Yagel, P. K. Lala, C. M. Overall, G. Norton, and J. Denhardt 1989. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243:947–950.
  • Knebelmann, B., S. Ananth, H. T. Cohen, and J. Sukhatme 1998. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor. Cancer Res. 58:226–231.
  • Konishi, T., T. Takehara, T. Tsuji, K. Ohsato, K. Matsumoto, and J. Nakamura 1991. Scatter factor from human embryonic lung fibroblasts is probably identical to hepatocyte growth factor. Biochem. Biophys. Res. Commun. 180:765–773.
  • Koochekpour, S., M. Jeffers, S. Rulong, E. Klineberg, G. Taylor, E. A. Hudson, J. H. Resau, and J. Vande Woude 1997. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res. 57:5391–5398.
  • Linehan, W. M., M. I. Lerman, and J. Zbar 1995. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. JAMA 273:564–570.
  • Liotta, L. A. 1986. Tumor invasion and metastases—role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 46:1–7.
  • Lonergan, K. M., O. Iliopoulos, M. Ohh, T. Kamura, R. C. Conaway, J. W. Conaway, W. G. Kaelin Jr.. 1998. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Mol. Cell. Biol. 18:732–741.
  • Maher, E. R., W. G. Kaelin Jr.. 1997. von Hippel-Lindau disease. Medicine (Baltimore) 76:381–391.
  • Matsumoto, K., K. Matsumoto, T. Nakamura, and J. Kramer 1994. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J. Biol. Chem. 269:31807–31813.
  • Matsumoto, K., and J. Nakamura 1992. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncog. 3:27–54.
  • Matsumoto, K., and J. Nakamura 1993. Roles of HGF as a pleiotropic factor in organ regeneration Hepatocyte growth factor-scatter factor and the Met Receptor In I. D. Goldberg, E. M. Rosen (ed.), 65:225–250 Birkhauser-Verlag, Basel, Switzerland.
  • Millan, J. C. 1989. Tumors of the kidney Uropathology In G. S. Hill (ed.), 2:623–701 Churchill Livingstone, New York, N.Y.
  • Montesano, R., K. Matsumoto, T. Nakamura, and J. Orci 1991. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Cell 67:901–908.
  • Morikawa, K., S. M. Walker, M. Nakajima, S. Pathak, J. M. Jessup, and J. Fidler 1988. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res. 48:6863–6871.
  • Nagaike, M., S. Hirao, H. Tajima, S. Noji, S. Taniguchi, K. Matsumoto, and J. Nakamura 1991. Renotropic functions of hepatocyte growth factor in renal regeneration after unilateral nephrectomy. J. Biol. Chem. 266:22781–22784.
  • Nakajima, M., D. R. Welch, P. N. Belloni, and J. Nicolson 1987. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47:4869–4876.
  • Nakayama, Y., S. Naito, M. Ryuto, Y. Hata, M. Ono, K. Sueishi, S. Komiyama, H. Itoh, and J. Kuwano 1996. An in vitro invasion model for human renal cell carcinoma cell lines mimicking their metastatic abilities. Clin. Exp. Metastasis 14:466–474.
  • Natali, P. G., M. Prat, M. R. Nicotra, A. Bigotti, M. Olivero, P. M. Comoglio, and J. Di Renzo 1996. Overexpression of the met/HGF receptor in renal cell carcinomas. Int. J. Cancer 69:212–217.
  • Otani, N., T. Tsukamoto, N. Masumori, I. Saiki, J. Yoneda, and J. Kumamoto 1994. Influence of growth factors on in vitro invasiveness and type IV collagenolysis of human renal cell carcinoma cells. J. Urol. 151:223–226.
  • Otani, N., T. Tsukamoto, I. Saiki, J. Yoneda, T. Mitaka, and J. Kumamoto 1993. In vitro invasive potential and type IV collagenolytic activity of human renal cell carcinoma cells derived from primary and metastatic lesions. J. Urol. 149:1182–1185.
  • Pause, A., S. Lee, K. M. Lonergan, and J. Klausner 1998. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc. Natl. Acad. Sci. USA 95:993–998.
  • Prat, M., R. P. Narsimhan, T. Crepaldi, M. R. Nicotra, P. G. Natali, and J. Comoglio 1991. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer 49:323–328.
  • Rong, S., M. Jeffers, J. H. Resau, I. Tsarfaty, M. Oskarsson, and J. Vande Woude 1993. Met expression and sarcoma tumorigenicity. Cancer Res. 53:5355–5360.
  • Rong, S., M. Oskarsson, D. Faletto, I. Tsarfaty, J. H. Resau, T. Nakamura, E. Rosen, R. F. Hopkins, and J. Vande Woude 1993. Tumorigenesis induced by co-expression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. Cell Growth Differ. 4:563–569.
  • Rong, S., S. Segal, M. Anver, J. H. Resau, and J. Vande Woude 1994. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. USA 91:4731–4735.
  • Sambrook, J., E. F. Fritsch, T. Maniatis 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
  • Schultz, R. M., S. Silberman, B. Persky, A. S. Bajkowski, and J. Carmichael 1988. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48:5539–5545.
  • Siemeister, G., K. Weindel, K. Mohrs, B. Barleon, G. Martiny-Baron, and J. Marme 1996. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res. 56:2299–2301.
  • Sonnenberg, E., D. Meyer, K. M. Weidner, and J. Birchmeier 1993. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:223–235.
  • Steiner, M. S. 1995. Review of peptide growth factors in benign prostatic hyperplasia and urological malignancy. J. Urol. 153:1085–1096.
  • Stetler-Stevenson, W. G., L. A. Liotta, and J. Kleiner 1993. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1434–1441.
  • Sugiura, Y., H. Shimada, R. C. Seeger, W. E. Laug, and J. DeClerck 1998. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis. Cancer Res. 58:2209–2216.
  • Tashiro, K., M. Hagiya, T. Nishizawa, T. Seki, M. Shimonishi, S. Shimizu, and J. Nakamura 1990. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc. Natl. Acad. Sci. USA 87:3200–3204.
  • Thorgeirsson, U. P., L. A. Liotta, T. Kalebic, I. M. Margulies, K. Thomas, M. Rios-Candelore, and J. Russo 1982. Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J. Natl. Cancer Inst. 69:1049–1054.
  • Tsao, M. S., H. Zhu, A. Giaid, J. Viallet, T. Nakamura, and J. Park 1993. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ. 4:571–579.
  • Tsarfaty, I., J. H. Resau, S. Rulong, I. Keydar, D. L. Faletto, and J. Vande Woude 1992. The met proto-oncogene receptor and lumen formation. Science 257:1258–1261.
  • Tsarfaty, I., S. Rong, J. H. Resau, S. Rulong, P. Pinto da Silva, and J. Vande Woude 1994. Met mediated signaling in mesenchymal to epithelial cell conversion. Science 263:98–101.
  • Tso, J. Y., X. H. Sun, T.-H. Kao, K. S. Reece, and J. Wu 1985. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res. 13:2485–2502.
  • Walther, M. M., D. E. Kleiner, I. A. Lubensky, R. Pozzatti, T. Nyguen, J. R. Gnarra, K. Hurley, D. Venzon, W. M. Linehan, and J. Stetler-Stevenson 1997. Progelatinase A mRNA expression in cell lines derived from tumors in patients with metastatic renal cell carcinoma correlates inversely with survival. Urology 50:295–301.
  • Woessner, J. F. Jr.. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145–2154.
  • Woolf, A. S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble, and J. Gherardi 1995. Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J. Cell Biol. 128:171–184.
  • Zarnegar, R., and J. DeFrances 1993. Expression of HGF-SF in normal and malignant human tissues. EXS 65:181–199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.